{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:03:38Z","timestamp":1764079418180,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-14-1-0073","W81XWH-12-1-0164","X81XWH-15-1-0193","W81XWH-14-1-0073","W81XWH-12-1-0164","X81XWH-15-1-0193"],"award-info":[{"award-number":["W81XWH-14-1-0073","W81XWH-12-1-0164","X81XWH-15-1-0193","W81XWH-14-1-0073","W81XWH-12-1-0164","X81XWH-15-1-0193"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08 NS083732","R01 NS095848","R01 NS102366"],"award-info":[{"award-number":["K08 NS083732","R01 NS095848","R01 NS102366"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA013696"],"award-info":[{"award-number":["P30 CA013696"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant peripheral nerve sheath tumors (MPNSTs) are the leading cause of death in neurofibromatosis type 1 (NF1) patients. Current treatment modalities have been largely unsuccessful in improving MPNST patient survival, making the identification of new therapeutic targets urgent. In this study, we found that interference with Usp9X, a deubiquitinating enzyme which is overexpressed in nervous system tumors, or Mcl-1, an anti-apoptotic member of the Bcl-2 family whose degradation is regulated by Usp9X, causes rapid death in human MPNST cell lines. Although both Usp9X and Mcl-1 knockdown elicited some features of apoptosis, broad spectrum caspase inhibition was ineffective in preventing knockdown-induced MPNST cell death suggesting that caspase-independent death pathways were also activated. Ultrastructural examination of MPNST cells following either Usp9X interference or pharmacological inhibition showed extensive cytoplasmic vacuolization and swelling of endoplasmic reticulum (ER) and mitochondria most consistent with paraptotic cell death. Finally, the Usp9X pharmacological inhibitor WP1130 significantly reduced human MPNST growth and induced tumor cell death in an <jats:italic>in vivo<\/jats:italic> xenograft model. In total, these findings indicate that Usp9X and Mcl-1 play significant roles in maintaining human MPNST cell viability and that pharmacological inhibition of Usp9X deubiquitinase activity could be a therapeutic target for MPNST treatment.<\/jats:p>","DOI":"10.1038\/s41598-018-35806-5","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T16:39:20Z","timestamp":1542731960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors"],"prefix":"10.1038","volume":"8","author":[{"given":"E.","family":"Bianchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Siegelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-995X","authenticated-orcid":false,"given":"K. A.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"35806_CR1","doi-asserted-by":"publisher","first-page":"7429697","DOI":"10.1155\/2017\/7429697","volume":"2017","author":"A Kim","year":"2017","unstructured":"Kim, A. et al. Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies. Sarcoma 2017, 7429697, https:\/\/doi.org\/10.1155\/2017\/7429697 (2017).","journal-title":"Sarcoma"},{"key":"35806_CR2","doi-asserted-by":"publisher","first-page":"8670","DOI":"10.18632\/oncotarget.14398","volume":"8","author":"CD Graham","year":"2017","unstructured":"Graham, C. D. et al. BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells. Oncotarget 8, 8670\u20138678, https:\/\/doi.org\/10.18632\/oncotarget.14398 (2017).","journal-title":"Oncotarget"},{"key":"35806_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/labinvest.2016.142","volume":"97","author":"M Kiuru","year":"2017","unstructured":"Kiuru, M. & Busam, K. J. The NF1 gene in tumor syndromes and melanoma. Lab Invest 97, 146\u2013157, https:\/\/doi.org\/10.1038\/labinvest.2016.142 (2017).","journal-title":"Lab Invest"},{"key":"35806_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.nec.2004.02.008","volume":"15","author":"DG Brooks","year":"2004","unstructured":"Brooks, D. G. The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors. Neurosurg Clin N Am 15, 145\u2013155, https:\/\/doi.org\/10.1016\/j.nec.2004.02.008 (2004).","journal-title":"Neurosurg Clin N Am"},{"key":"35806_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brainresbull.2011.08.005","volume":"88","author":"NM Brossier","year":"2012","unstructured":"Brossier, N. M. & Carroll, S. L. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brain Res Bull 88, 58\u201371, https:\/\/doi.org\/10.1016\/j.brainresbull.2011.08.005 (2012).","journal-title":"Brain Res Bull"},{"key":"35806_CR6","doi-asserted-by":"publisher","first-page":"12791","DOI":"10.18632\/oncotarget.7302","volume":"7","author":"G Karpel-Massler","year":"2016","unstructured":"Karpel-Massler, G. et al. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo. Oncotarget 7, 12791\u201312805, https:\/\/doi.org\/10.18632\/oncotarget.7302 (2016).","journal-title":"Oncotarget"},{"key":"35806_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.281","volume":"5","author":"J Yan","year":"2014","unstructured":"Yan, J. et al. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells. Cell Death Dis 5, e1316, https:\/\/doi.org\/10.1038\/cddis.2014.281 (2014).","journal-title":"Cell Death Dis"},{"key":"35806_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.15252\/emmm.201506047","volume":"8","author":"K Engel","year":"2016","unstructured":"Engel, K. et al. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO Mol Med 8, 851\u2013862, https:\/\/doi.org\/10.15252\/emmm.201506047 (2016).","journal-title":"EMBO Mol Med"},{"key":"35806_CR9","doi-asserted-by":"publisher","first-page":"36456","DOI":"10.18632\/oncotarget.5505","volume":"6","author":"G Karpel-Massler","year":"2015","unstructured":"Karpel-Massler, G. et al. TIC10\/ONC201 synergizes with Bcl-2\/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo. Oncotarget 6, 36456\u201336471, https:\/\/doi.org\/10.18632\/oncotarget.5505 (2015).","journal-title":"Oncotarget"},{"key":"35806_CR10","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1080\/15384101.2015.1078033","volume":"14","author":"JS Nair","year":"2015","unstructured":"Nair, J. S. & Schwartz, G. K. Inhibition of polo like kinase 1 in sarcomas induces apoptosis that is dependent on Mcl-1 suppression. Cell Cycle 14, 3101\u20133111, https:\/\/doi.org\/10.1080\/15384101.2015.1078033 (2015).","journal-title":"Cell Cycle"},{"key":"35806_CR11","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1158\/0008-5472.CAN-16-3424","volume":"77","author":"G Karpel-Massler","year":"2017","unstructured":"Karpel-Massler, G. et al. Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses. Cancer research 77, 3513\u20133526, https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3424 (2017).","journal-title":"Cancer research"},{"key":"35806_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.485","volume":"8","author":"M Milani","year":"2017","unstructured":"Milani, M. et al. DRP-1 is required for BH3 mimetic-mediated mitochondrial fragmentation and apoptosis. Cell Death Dis 8, e2552, https:\/\/doi.org\/10.1038\/cddis.2016.485 (2017).","journal-title":"Cell Death Dis"},{"key":"35806_CR13","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/jcp.22956","volume":"227","author":"WB Wang","year":"2012","unstructured":"Wang, W. B. et al. Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. J Cell Physiol 227, 2196\u20132206, https:\/\/doi.org\/10.1002\/jcp.22956 (2012).","journal-title":"J Cell Physiol"},{"key":"35806_CR14","doi-asserted-by":"publisher","first-page":"e57779","DOI":"10.1371\/journal.pone.0057779","volume":"8","author":"JS Zhang","year":"2013","unstructured":"Zhang, J. S. et al. gamma-Tocotrienol induces paraptosis-like cell death in human colon carcinoma SW620 cells. PLoS One 8, e57779, https:\/\/doi.org\/10.1371\/journal.pone.0057779 (2013).","journal-title":"PLoS One"},{"key":"35806_CR15","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1182\/blood-2014-10-605584","volume":"125","author":"LF Peterson","year":"2015","unstructured":"Peterson, L. F. et al. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. Blood 125, 3588\u20133597, https:\/\/doi.org\/10.1182\/blood-2014-10-605584 (2015).","journal-title":"Blood"},{"key":"35806_CR16","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1073\/pnas.1322198111","volume":"111","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. Proc Natl Acad Sci USA 111, 4251\u20134256, https:\/\/doi.org\/10.1073\/pnas.1322198111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35806_CR17","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1158\/1535-7163.MCT-10-0238","volume":"9","author":"LV Pham","year":"2010","unstructured":"Pham, L. V. et al. Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications. Mol Cancer Ther 9, 2026\u20132036, https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0238 (2010).","journal-title":"Mol Cancer Ther"},{"key":"35806_CR18","doi-asserted-by":"publisher","first-page":"14507","DOI":"10.18632\/oncotarget.3993","volume":"6","author":"G Karpel-Massler","year":"2015","unstructured":"Karpel-Massler, G. et al. Combined inhibition of Bcl-2\/Bcl-xL and Usp9X\/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo. Oncotarget 6, 14507\u201314521, https:\/\/doi.org\/10.18632\/oncotarget.3993 (2015).","journal-title":"Oncotarget"},{"key":"35806_CR19","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00018-015-1851-0","volume":"72","author":"M Murtaza","year":"2015","unstructured":"Murtaza, M., Jolly, L. A., Gecz, J. & Wood, S. A. La FAM fatale: USP9X in development and disease. Cell Mol Life Sci 72, 2075\u20132089, https:\/\/doi.org\/10.1007\/s00018-015-1851-0 (2015).","journal-title":"Cell Mol Life Sci"},{"key":"35806_CR20","doi-asserted-by":"publisher","first-page":"79515","DOI":"10.18632\/oncotarget.12819","volume":"7","author":"B Yang","year":"2016","unstructured":"Yang, B. et al. Deubiquitinase USP9X deubiquitinates beta-catenin and promotes high grade glioma cell growth. Oncotarget 7, 79515\u201379525, https:\/\/doi.org\/10.18632\/oncotarget.12819 (2016).","journal-title":"Oncotarget"},{"key":"35806_CR21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.4161\/cbt.29182","volume":"15","author":"JL Cox","year":"2014","unstructured":"Cox, J. L. et al. Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Cancer Biol Ther 15, 1042\u20131052, https:\/\/doi.org\/10.4161\/cbt.29182 (2014).","journal-title":"Cancer Biol Ther"},{"key":"35806_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nature11114","volume":"486","author":"PA Perez-Mancera","year":"2012","unstructured":"Perez-Mancera, P. A. et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486, 266\u2013270, https:\/\/doi.org\/10.1038\/nature11114 (2012).","journal-title":"Nature"},{"key":"35806_CR23","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1158\/0008-5472.CAN-10-1530","volume":"70","author":"V Kapuria","year":"2010","unstructured":"Kapuria, V. et al. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. Cancer research 70, 9265\u20139276, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1530 (2010).","journal-title":"Cancer research"},{"key":"35806_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-385114-7.00004-0","volume":"490","author":"CM Oslowski","year":"2011","unstructured":"Oslowski, C. M. & Urano, F. Measuring ER stress and the unfolded protein response using mammalian tissue culture system. Methods Enzymol 490, 71\u201392, https:\/\/doi.org\/10.1016\/B978-0-12-385114-7.00004-0 (2011).","journal-title":"Methods Enzymol"},{"key":"35806_CR25","doi-asserted-by":"publisher","first-page":"29558","DOI":"10.18632\/oncotarget.16365","volume":"8","author":"CT Ishida","year":"2017","unstructured":"Ishida, C. T. et al. BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma. Oncotarget 8, 29558\u201329573, https:\/\/doi.org\/10.18632\/oncotarget.16365 (2017).","journal-title":"Oncotarget"},{"key":"35806_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1517\/14728222.2012.728207","volume":"16","author":"DC Singleton","year":"2012","unstructured":"Singleton, D. C. & Harris, A. L. Targeting the ATF4 pathway in cancer therapy. Expert Opin Ther Targets 16, 1189\u20131202, https:\/\/doi.org\/10.1517\/14728222.2012.728207 (2012).","journal-title":"Expert Opin Ther Targets"},{"key":"35806_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08646","volume":"463","author":"M Schwickart","year":"2010","unstructured":"Schwickart, M. et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463, 103\u2013107, https:\/\/doi.org\/10.1038\/nature08646 (2010).","journal-title":"Nature"},{"key":"35806_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1593\/neo.12598","volume":"14","author":"D Trivigno","year":"2012","unstructured":"Trivigno, D., Essmann, F., Huber, S. M. & Rudner, J. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1. Neoplasia 14, 893\u2013904 (2012).","journal-title":"Neoplasia"},{"key":"35806_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.561","volume":"6","author":"JD Leverson","year":"2015","unstructured":"Leverson, J. D. et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Cell Death Dis 6, e1590, https:\/\/doi.org\/10.1038\/cddis.2014.561 (2015).","journal-title":"Cell Death Dis"},{"key":"35806_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-541","volume":"12","author":"C Peddaboina","year":"2012","unstructured":"Peddaboina, C. et al. The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition. BMC Cancer 12, 541, https:\/\/doi.org\/10.1186\/1471-2407-12-541 (2012).","journal-title":"BMC Cancer"},{"key":"35806_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jnr.490370314","volume":"37","author":"JJ Ryan","year":"1994","unstructured":"Ryan, J. J. et al. Role for the stem cell factor\/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. J Neurosci Res 37, 415\u2013432, https:\/\/doi.org\/10.1002\/jnr.490370314 (1994).","journal-title":"J Neurosci Res"},{"key":"35806_CR32","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1038\/sj.onc.1208730","volume":"24","author":"MS Stonecypher","year":"2005","unstructured":"Stonecypher, M. S., Byer, S. J., Grizzle, W. E. & Carroll, S. L. Activation of the neuregulin-1\/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene 24, 5589\u20135605, https:\/\/doi.org\/10.1038\/sj.onc.1208730 (2005).","journal-title":"Oncogene"},{"key":"35806_CR33","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1172\/JCI44855","volume":"121","author":"MD Siegelin","year":"2011","unstructured":"Siegelin, M. D. et al. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest 121, 1349\u20131360, https:\/\/doi.org\/10.1172\/JCI44855 (2011).","journal-title":"J Clin Invest"},{"key":"35806_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/neuonc\/nop048","volume":"12","author":"Y Geng","year":"2010","unstructured":"Geng, Y., Kohli, L., Klocke, B. J. & Roth, K. A. Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. Neuro Oncol 12, 473\u2013481, https:\/\/doi.org\/10.1093\/neuonc\/nop048 (2010).","journal-title":"Neuro Oncol"},{"key":"35806_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1158\/1541-7786.MCR-13-0650","volume":"12","author":"F Pareja","year":"2014","unstructured":"Pareja, F. et al. PI3K and Bcl-2 inhibition primes glioblastoma cells to apoptosis through downregulation of Mcl-1 and Phospho-BAD. Mol Cancer Res 12, 987\u20131001, https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0650 (2014).","journal-title":"Mol Cancer Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35806-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35806-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35806-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T12:01:13Z","timestamp":1671624073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35806-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35806-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17390"}}